Primary antibiotic resistance of Helicobacter pylori in India over the past two decades: A systematic review
Helicobacter · 2024
DOI: 10.1111/hel.13057 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Helicobacter, 2024. Verfasst von Spriha Dutta und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Medical Biotechnology, Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Background
Helicobacter pylori antibiotic resistance has undergone vast changes in the last two decades. No systematic review has been done on the prevalence of antibiotic resistant H. pylori in India in the last two decades. We evaluated the pattern of resistance rates across various regions of India. Materials and Methods A systematic review of the geographical variations in antibiotic resistance pattern of H. pylori was conducted using PubMed, Google Scholar, Web of Science, Science Direct, etc. for articles published between January 1, 2000 and May 30, 2023. Random effects‐model‐based Cochran's Q test, I 2 statistics, and chi‐squared tests were used to measure heterogeneity.
Results
The overall resistance was highest against metronidazole (77.65%) followed by amoxicillin (37.78%), levofloxacin (32.8%), clarithromycin (35.64%), furazolidone (12.03%), and tetracycline (11.63%). 14.7% of the H. pylori isolates were multi‐drug resistant. Under meta‐analysis of each antibiotic, high heterogeneity levels were observed having I 2 ranges from 86.53% to 97.70% at p < 0.0001. In sub‐group analysis, Metronidazole has a stable rate of resistance as compared to other antibiotics. Other antibiotics have had a downtrend in the last 5 years except for levofloxacin, which has had an uptrend in the resistance rate for the past 5 years. Hence, one should avoid using metronidazole for any kind of first‐line treatment.
Conclusions
Metronidazole resistance is high in most regions of India except Assam and Mumbai while clarithromycin is found to be ineffective in South India, Gujarat, and Kashmir. As compared to other antibiotics, resistance to amoxicillin is generally low except in certain regions (Hyderabad, Chennai, and the Gangetic belt of North India). Tetracycline and Furazolidone have the least resistance rates and should be part of anti‐ H. pylori regimens. The resurgence of high single and multidrug resistance to the commonly used drugs suggests the need for newer antibiotics and regular resistance surveillance studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Medical Biotechnology, Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India.
- Department of Gastroenterology, Yashoda Superspeciality Hospital, Kausambi, Ghaziabad, Uttar Pradesh, India.
- Department of Statistics, University of Allahabad, Prayagraj, Uttar Pradesh, India.
- Centre of Bioinformatics, Institute of Interdisciplinary Studies, University of Allahabad, Prayagraj, Uttar Pradesh, India.
Zitieren
APA
Dutta, S., Jain, S., Das, K., Verma, P., Som, A., & Das, R. (2024). Primary antibiotic resistance of Helicobacter pylori in India over the past two decades: A systematic review. Helicobacter. https://doi.org/10.1111/hel.13057
Vancouver
Dutta S, Jain S, Das K, Verma P, Som A, Das R. Primary antibiotic resistance of Helicobacter pylori in India over the past two decades: A systematic review. Helicobacter. 2024. doi:10.1111/hel.13057
BibTeX
@article{Dutta2024,
author = {Dutta, Spriha and Jain, Surbhi and Das, Kunal and Verma, Prashant and Som, Anup and Das, Rajashree},
title = {Primary antibiotic resistance of Helicobacter pylori in India over the past two decades: A systematic review},
journal = {Helicobacter},
year = {2024},
doi = {10.1111/hel.13057}
}
EUVIMED